...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: possible catalyst(s)??

What’s the next possible catalyst(s) coming for Zenith that could give this thing a pop? Wasn't there some results/readouts coming/expected this month?

This expert market is bunk. Will Don ever give us a ligament liquidity event?

Share
New Message
Please login to post a reply